The World’s First AI Genomic-Based Skincare Line
Designed to Address Japanese and Asian Environmental Skin Aging
TOKYO, Dec. 09, 2025 — (Japanese corporate name: Genesis Healthcare Co.), the leading Japanese company in genomics and AI-driven preventive wellness and therapeutics, today announced the introduction of ALUNAÉ, the inaugural skincare line based on genomics created to combat environmental aging specific to Japanese and Asian skin.
Introducing ALUNAÉ
Skincare for Environmental Aging, Shaped by Genetics
Utilizing Japan’s most extensive genomic population database, ALUNAÉ marks a new chapter for skincare. AI-driven genomic intelligence guides the selection, combination, and optimization of ingredients to counteract the quantifiable impacts of environmental aging, such as UV exposure, pollution, humidity fluctuations, and oxidative stress.
AI × Genomics
Mapping the Impact of Ingredients on the Skin’s Deeper Biology
This methodology is backed by research featured in “A Score-Based Rapid Screening and Network Visualization Method Based on Bioactive Ingredient-Induced Variations in Skin Cell Gene Expression” (Scientia Pharmaceutica, November, 2025), which confirms the screening of bioactive ingredients according to their genetic influence.
A Legacy of Smart Balance
GA-6 (Geno Active-6)
From this research arose GA-6 (Geno Active-6), a blend of six bioactive components selected for their connection to biological pathways associated with hydration, radiance, and adaptation to environmental stress.
ALUNAÉ was created under the guidance of Dr. Tadayoshi Miyashita, a preeminent authority in Japanese cosmetic science with over fifty years of experience. His expertise was instrumental in developing GA-6 to pinpoint ingredients that safeguard Japanese and Asian skin from UV radiation, dryness, airborne particles, and urban pollution.
“At A.D.A.M. Innovations, our goal is to enhance beauty through scientific innovation that is as dynamic as our environment,” stated Michel Mommejat, President of A.D.A.M. Innovations. “ALUNAÉ propels cosmetic science forward by leveraging genomic intelligence, creating a path for bespoke formulations tailored to the genetic requirements of Japanese and Asian skin.”
Introducing the ALUNAÉ collection
ALUNAÉ is launched today, December 9, 2025, available solely via GeneLife e-commerce, with a targeted retail rollout scheduled for 2026.
The initial collection features two flagship products, ALUNAÉ Treatment Cream (JPY 14,800) and ALUNAÉ Treatment Essence (JPY 14,800), designed to work together as a comprehensive regimen against environmental aging.
To mark the launch, a limited-edition gift set containing both products will be available for JPY 29,600, providing a sophisticated entry into the ALUNAÉ line.
For additional information, please visit:
About A.D.A.M. Innovations Co.
Established in 2004 in Tokyo, A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare Co.) is a pioneer in genomics, artificial intelligence, and precision health. The company creates advanced technologies across consumer genetics, clinical diagnostics, and AI-powered R&D data platforms. A.D.A.M. Innovations has performed over 2.8 million genetic tests to date and holds the largest R&D genomic database for the Japanese population.
About GeneLife
GeneLife is the consumer genetics brand under A.D.A.M. Innovations. It provides genetic testing directly to consumers via at-home kits and online stores. Commanding a 74% market share (source: Fuji Kimera), GeneLife is the dominant market leader, offering personalized health and wellness information to help individuals achieve a better quality of life and longevity.
ALUNAÉ and GeneLife are registered trademarks of A.D.A.M. Innovations Co.
Corporate contact:
Email: press@adam-innnovations.com
Media Relations:
Crocker Coulson
Email: Crocker.Coulson@aumadvisors.com
+1 (646) 652-7185
